title: Medical treatment of benign prostatic hyperplasia.
abstract: Pharmaceutical preparations are commonly used for benign prostate hyperplasia. This article reviews the current understanding of the natural history of the condition and the literature regarding medical treatment.
authors.affiliation: Mater Misericordiae Hospital, Dublin, Ireland. steconnolly@rcsi.ie
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Connolly
authors.forename: John M
authors.initials: JM
authors.lastname: Fitzpatrick
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001378:Azasteroids / Q000627:therapeutic use; D000068538:Dutasteride; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008517:Phytotherapy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000209:etiology
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D001378:Azasteroids; D004791:Enzyme Inhibitors; D018120:Finasteride; D000068538:Dutasteride